AR042000A1 - Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados - Google Patents

Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados

Info

Publication number
AR042000A1
AR042000A1 ARP030104096A ARP030104096A AR042000A1 AR 042000 A1 AR042000 A1 AR 042000A1 AR P030104096 A ARP030104096 A AR P030104096A AR P030104096 A ARP030104096 A AR P030104096A AR 042000 A1 AR042000 A1 AR 042000A1
Authority
AR
Argentina
Prior art keywords
patients
fosinopril
dialized
cardiovascular events
reduce cardiovascular
Prior art date
Application number
ARP030104096A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR042000A1 publication Critical patent/AR042000A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

Uso de fosinopril o una de sus sales farmacéuticamente aceptables, para reducir el riesgo de ocurrencia de un evento cardiovascular en pacientes dializados, en donde el evento cardiovascular es una insuficiencia cardíaca, en particular en pacientes hemodializados, especialmente pacientes que presentan una hipertrofia ventricular izquierda.
ARP030104096A 2002-11-08 2003-11-07 Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados AR042000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0214060A FR2846886A1 (fr) 2002-11-08 2002-11-08 Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses

Publications (1)

Publication Number Publication Date
AR042000A1 true AR042000A1 (es) 2005-06-08

Family

ID=32116508

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104096A AR042000A1 (es) 2002-11-08 2003-11-07 Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados

Country Status (14)

Country Link
US (1) US20060135482A1 (es)
EP (1) EP1558267A1 (es)
JP (1) JP2006506405A (es)
KR (1) KR20050072480A (es)
CN (1) CN1708308A (es)
AR (1) AR042000A1 (es)
AU (1) AU2003278059A1 (es)
BR (1) BR0316059A (es)
CA (1) CA2505324A1 (es)
FR (1) FR2846886A1 (es)
MX (1) MXPA05004753A (es)
PL (1) PL374906A1 (es)
WO (1) WO2004041290A1 (es)
ZA (1) ZA200504652B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006100602A2 (en) * 2005-03-22 2006-09-28 Aurobindo Pharma Ltd Immediate release stable solid oral dosage forms op fosinopril
TWI412361B (zh) * 2005-07-08 2013-10-21 Mochida Pharm Co Ltd 預防心血管症候用組成物
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
WO2003013434A2 (en) * 2001-08-06 2003-02-20 Genomed, Llc Methods and compositions for treating diseases associated with excesses in ace
NZ534544A (en) * 2002-02-28 2007-05-31 Novartis Ag N- {5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl} -4-(3-pyridyl)-2-pyrimidine-amine coated stents

Also Published As

Publication number Publication date
AU2003278059A1 (en) 2004-06-07
CA2505324A1 (en) 2004-05-21
MXPA05004753A (es) 2005-08-02
BR0316059A (pt) 2005-09-27
WO2004041290A1 (en) 2004-05-21
ZA200504652B (en) 2006-03-29
FR2846886A1 (fr) 2004-05-14
PL374906A1 (en) 2005-11-14
JP2006506405A (ja) 2006-02-23
CN1708308A (zh) 2005-12-14
KR20050072480A (ko) 2005-07-11
EP1558267A1 (en) 2005-08-03
US20060135482A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
AR018719A1 (es) Inhibidores de renina.
CO5570670A2 (es) Pulmonar obstructiva cronica
NO20044436L (no) Substituerte fenyleddiksyrer
AR018717A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS.
UY27665A1 (es) Nuevos derivados de piridina y pirimidina
NO20060416L (no) Ny anvendelse I
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
BR0209948A (pt) Inibidores de fator inibitório de migração de macrófago e métodos para identificar os mesmos
BR0307590A (pt) Laminado
AR109263A2 (es) Composición que comprende moxidectina
SV2004001756A (es) Nueva difenilazetidinona con propiedades fisiologicas mejoraradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso
UY27462A1 (es) Derivados de quinolina
AR056800A1 (es) Uso de inhibidores de la pde iii para el tratamiento de la isuficiencia cardiaca asintomatica ( oculta )
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
AR039633A2 (es) Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
PA8548501A1 (es) Nuevos derivados de acido sulfonico
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
DK1377164T3 (da) Erythropoietin forbedrer kemoterapi-induceret toksicitet in vivo
SE0201940D0 (sv) New combination II
AR042000A1 (es) Uso de fosinopril para reducir los eventos cardiovasculares en pacientes dializados
NO20054349L (no) Kombinert terapi mot kreft omfattende nemorubicin med stralingsterapi
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
UY27910A1 (es) Uso de un derivado de amina cíclica específico o de sus sales farmacéuticamente aceptables para tratar o prevenir la insuficiencia cardiaca

Legal Events

Date Code Title Description
FB Suspension of granting procedure